TETRAPHASE PHARMACEUTICALS INC Financing Cash Flow
TETRAPHASE PHARMACEUTICALS INC reported Financing Cash Flow of $15.93 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was $15.93M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $7.10M, a 75.61% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was -$30.48M, a 1436.26% decline year-over-year.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2018-12-31 was $29.09M, a 1417.53% increase year-over-year.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2019 was -$23.34M, a 164.05% decline from fiscal 2018.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2018 was $36.45M, a 60.87% decline from fiscal 2017.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2017 was $93.15M.
- TETRAPHASE PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2013 was $118.27M, a 3445.20% increase from fiscal 2012.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 81 month | Net Cash Provided by (Used in) Financing Activities 84 month | Net Cash Provided by (Used in) Financing Activities 87 month | Net Cash Provided by (Used in) Financing Activities 90 month |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $15.93M 10-Q · filed 2020-05-07 | $23.03M derived: sum of 2 quarters · filed 2020-05-07 | -$7.45M derived: sum of 3 quarters · filed 2020-05-07 | |||||
| 2019-12-31 | $7.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$23.38M derived: sum of 2 quarters · filed 2020-03-12 | -$23.34M 10-K · filed 2020-03-12 | |||||
| 2019-09-30 | -$30.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$30.44M 10-Q · filed 2019-11-12 | ||||||
| 2019-06-30 | $39.00K 10-Q · filed 2019-08-08 | |||||||
| 2018-12-31 | $29.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $31.37M derived: sum of 2 quarters · filed 2020-03-12 | $36.22M derived: sum of 3 quarters · filed 2020-03-12 | $36.45M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $2.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $7.13M derived: sum of 2 quarters · filed 2019-11-12 | $7.36M 10-Q · filed 2019-11-12 | $9.27M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $4.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $5.08M 10-Q · filed 2019-08-08 | $6.99M derived: sum of 3 quarters · filed 2019-08-08 | $76.22M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $231.00K 10-Q · filed 2019-05-08 | $2.15M derived: sum of 2 quarters · filed 2019-05-08 | $71.38M derived: sum of 3 quarters · filed 2019-05-08 | |||||
| 2017-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $71.15M derived: sum of 2 quarters · filed 2019-03-15 | $93.15M 10-K · filed 2019-03-15 | |||||
| 2017-09-30 | $69.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $91.23M 10-Q · filed 2018-11-09 | ||||||
| 2017-06-30 | $22.00M 10-Q · filed 2018-08-02 | |||||||
| 2013-12-31 | $44.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $42.86M derived: sum of 2 quarters · filed 2014-03-06 | $46.62M derived: sum of 3 quarters · filed 2014-03-06 | $118.27M 10-K · filed 2014-03-06 | $209.39M 10-K · filed 2014-03-06 | |||
| 2013-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $2.45M derived: sum of 2 quarters · filed 2013-11-14 | $74.10M 10-Q · filed 2013-11-14 | $78.93M derived: sum of 4 quarters · filed 2014-03-06 | $165.22M 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $75.41M 10-Q · filed 2013-08-12 | $80.24M derived: sum of 3 quarters · filed 2014-03-06 | $79.58M derived: sum of 4 quarters · filed 2014-03-06 | $166.53M 10-Q · filed 2013-08-12 | |||
| 2013-03-31 | $71.65M 10-Q · filed 2013-05-13 | $76.48M derived: sum of 2 quarters · filed 2014-03-06 | $75.83M derived: sum of 3 quarters · filed 2014-03-06 | $75.19M derived: sum of 4 quarters · filed 2014-03-06 | $162.13M 10-Q · filed 2013-05-13 | |||
| 2012-12-31 | $4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $4.17M derived: sum of 2 quarters · filed 2014-03-06 | $3.54M derived: sum of 3 quarters · filed 2014-03-06 | $3.34M 10-K · filed 2014-03-06 | ||||
| 2012-09-30 | -$657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$1.29M derived: sum of 2 quarters · filed 2013-11-14 | -$1.49M 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$630.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$837.00K 10-Q · filed 2013-08-12 | ||||||
| 2012-03-31 | -$207.00K 10-Q · filed 2013-05-13 | |||||||
| 2011-12-31 | $7.81M 10-K · filed 2014-03-06 |